Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 April 2021 | Story Nonsindiso Qwabe | Photo Sonia SMall

How has COVID-19 further widened the gender inequality gap in the workplace?

This was the central question addressed during the first instalment of a webinar series on Gender and Social Justice hosted by the Unit for Institutional Change and Social Justice at the University of the Free State (UFS). The webinar, which was hosted on the UFS Qwaqwa Campus on 29 March 2021, featured Prof Pearl Sithole, Qwaqwa Campus Vice-Principal: Academic and Research; Advocate Nthabiseng Sepanya-Mogale, Commissioner at the Commission for Gender Equality (CGE); and Tholo Motaung, skills trainer, moderator, and gender activist at the Vaal University of Technology as panellists. 

Prof Sithole said COVID-19 revealed the disparity that still exists between men and women in the workplace. “COVID-19 has been the magnifier. We’ve modernised quite a lot, but we’re still unequal in terms of gender. Why are we not progressing in terms of women moving forward towards equality when there has been so much progressive thinking in the political space, social justice space, as well as in the kind of feminism we have had in academia? Why are we actually not winning the battle of just regarding each other as equals?” 

Women hardest hit by COVID-19 lockdown

Advocate Sepanya-Mogale said the lockdown revealed the gender gap mostly through the significant impact it has had on South African women.

In 2020, 34% of the country’s workforce comprised women – a sharp decline of 9,8% from 43,8% in 2018.
“This decline is alarming and a clear indication of who becomes the first victims, but that is hardly talked about. A lot of women have experienced resistance from industries they had been serving diligently,” she said. She said women were often faced with the burden of integrating their work with increased care responsibilities for their children and sometimes also the elderly as primary caregivers. The double responsibility placed on women continues to re-enforce gender roles in our societies and further pushes away the success of closing the gap on gender equality prospects in our society.

Advocate Sepanya-Mogale said women were the hardest hit in most industries. In the beauty and tourism industry; air transportation; informal trading; and healthcare sector to name a few, women bore the brunt the most. “Women are the biggest employees on all economic levels in South Africa, especially the low-income and unskilled levels,” she said.
She said as the spread of the virus was likely to continue disrupting economic activity, all sectors of society needed to get involved and play their part.

“As disease outbreaks are not likely to disappear in the near future, proactive international action is required to not only save lives but to also protect economic prosperity. Academic institutions are authorities in terms of opening up new discussions, leading new debates, and putting critical issues at the centre of the table. Let us all do what we can so that we empower our people relevantly for the times we’re living in.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept